查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1842313

全球梅毒檢測市場：市場規模、佔有率、趨勢分析（按技術、檢測地點和地區分類）、細分市場預測（2025-2033 年）

Syphilis Testing Market Size Share & Trends Analysis Report By Technology (Molecular Diagnostics, Immunoassay), By Location of Testing (Laboratory Testing, Point Of Care Testing), By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 236 Pages | 商品交期: 2-10個工作天內

價格

梅毒檢測：市場概覽

全球梅毒檢測市場預計在 2024 年達到 5.1521 億美元，預計到 2033 年將達到 13.756 億美元，2025 年至 2033 年的複合年成長率為 11.89%。

HIV/梅毒雙重快速診斷的主要市場促進因素是先天性梅毒和 HIV 合併感染在全球日益嚴重的負擔，這繼續對懷孕產生重大不利影響。

世界衛生組織和各國衛生部門日益重視消除母嬰傳播（EMTCT）項目，這催生了對經濟高效的即時檢測（PoC）解決方案的強勁需求。加拿大衛生署批准MedMira公司的Multiplo快速TP/HIV檢測等監管核准，以及CHAI-MedAccess-SD生物感測器等夥伴關係，透過確保價格可承受性和可及性，加速了即時檢測解決方案的普及應用。核准，在農村和醫療服務不足地區推行分散式檢查也推動了即時檢測解決方案的廣泛應用，而檢測準確性和速度的技術進步則增強了市場信心。

梅毒曾被認為是一種過時的疾病，如今卻在北美乃至全球範圍內再次成為重要的公共衛生和市場問題。儘管20世紀中期青黴素的廣泛應用幾乎在高所得國家根除了梅毒，但近年來梅毒疫情迅速反彈。在美國，2018年至2022年間報告的梅毒病例增加了80%以上，從約11.5萬例增至超過20.7萬例，達到20世紀50年代以來的最高水準。尤其令人擔憂的是先天性梅毒，同期病例增加了183%，反映出孕產婦篩檢和早期療育的差距。在加拿大，草原省份和北部地區的發病率上升進一步凸顯了及時診斷和治療方面存在的差距，尤其是在原住民群體中。這些流行病學變化正在催生對創新診斷解決方案、分散式檢查模式和可擴展的公共衛生干預措施日益成長的需求，使感染疾病診斷市場加速成長。

目錄

第1章 梅毒檢測市場：分析方法與範圍

2. 梅毒檢測市場：執行摘要

  • 市場概述
  • 按技術和檢查區域分類的簡介
  • 按癌症類型和功能分類的簡介
  • 競爭格局概覽

3. 梅毒檢測市場：影響因素、趨勢與範圍

  • 市場區隔及範圍
  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 梅毒檢測市場：依技術分類的估算與趨勢分析

  • 梅毒檢測市場：依技術分類的差異分析
  • 分子診斷
  • 免疫檢測
  • 其他

第5章 梅毒檢測市場：依檢測點分類的估算與趨勢分析

  • 梅毒檢測市場：波動分析（依檢測點分類）
  • 實驗室測試
    • 商業/私人實驗室
    • 公共衛生實驗室
  • 照護現場偵測 (PoC)

6. 梅毒檢測市場：按地區分類的業務分析

  • 市場概覽：按地區分類
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第7章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品上市
    • 商業夥伴關係
    • 企業收購
    • 商業合作
    • 資金籌措
  • 主要企業市佔率分析（2024 年）
  • 公司熱力圖分析
  • 公司簡介
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Danaher Corporation（Beckman Coulter）
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • OraSure Technologies, Inc.
    • Chembio Diagnostics, Inc.
    • SD Biosensor, Inc.
Product Code: GVR-4-68040-747-4

Syphilis Testing Market Summary

The global syphilis testing market size was estimated at USD 515.21 million in 2024 and is projected to reach USD 1,375.60 million by 2033, growing at a CAGR of 11.89% from 2025 to 2033. Key market growth drivers for dual HIV/syphilis rapid diagnostics include the rising global burden of congenital syphilis and HIV co-infections, which continue to cause significant adverse pregnancy outcomes.

Growing emphasis on elimination of mother-to-child transmission (EMTCT) programs by the WHO and national health bodies is creating strong demand for cost-effective, point-of-care solutions. Regulatory approvals, such as Health Canada's clearance of MedMira's Multiplo Rapid TP/HIV Test, and partnerships like CHAI-MedAccess-SD Biosensor, are accelerating adoption by ensuring affordability and accessibility. Additionally, the push for decentralized testing in rural and underserved regions supports uptake, while technological improvements in accuracy and speed enhance market confidence.

Syphilis, once considered a disease of the past, has reemerged as a significant public health and market concern in North America and globally. While the widespread use of penicillin in the mid-20th century had nearly eliminated syphilis in high-income countries, recent years have seen a sharp resurgence. In the U.S., reported cases increased by more than 80% between 2018 and 2022, rising from approximately 115,000 to over 207,000-the highest level since the 1950s. Of particular concern is congenital syphilis, which grew by 183% during the same period, reflecting gaps in maternal screening and early intervention. In Canada, rising incidence in the Prairie provinces and northern territories-particularly among Indigenous populations further highlights disparities in access to timely diagnostics and treatment. These epidemiological shifts are creating heightened demand for innovative diagnostic solutions, decentralized testing models, and scalable public health interventions, positioning the infectious disease diagnostics market for accelerated growth.

Global Syphilis Testing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syphilis testing market report based on technology, location of testing, cancer type, function, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Molecular Diagnostics
  • Immunoassay
  • Others
  • Location of Testing Outlook (Revenue, USD Million, 2021 - 2033)
  • Laboratory Testing
    • Commercial/Private labs
    • Public Health Labs
  • Point of Care Testing
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Syphilis Testing Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Technology Segment
      • 1.1.1.2. Location of Testing Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Syphilis Testing Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Technology and Location of Testing Snapshot
  • 2.3. Cancer Type and Function Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Syphilis Testing Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
  • 3.5. Market Restraint Analysis
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Syphilis Testing Market: Technology Estimates & Trend Analysis

  • 4.1. Syphilis Testing Market: Technology Movement Analysis
  • 4.2. Molecular Diagnostics
    • 4.2.1. Molecular Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay
    • 4.3.1. Immunoassay Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syphilis Testing Market: Location of Testing Estimates & Trend Analysis

  • 5.1. Syphilis Testing Market: Location of Testing Movement Analysis
  • 5.2. Laboratory Testing
    • 5.2.1. Laboratory Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Commercial/Private labs
      • 5.2.2.1. Commercial/Private labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Public Health Labs
      • 5.2.3.1. Public Health Labs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Point of Care Testing
    • 5.3.1. Point of Care Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syphilis Testing Market: Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Syphilis Testing Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Reimbursement Scenario
      • 6.2.2.5. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Reimbursement Scenario
      • 6.2.3.5. Competitive Scenario
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.2.4.2. Key Country Dynamics
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Reimbursement Scenario
      • 6.2.4.5. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. Competitive Scenario
    • 6.3.3. Germany
      • 6.3.3.1. Germany Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. Competitive Scenario
    • 6.3.4. Spain
      • 6.3.4.1. Spain Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. Competitive Scenario
    • 6.3.5. France
      • 6.3.5.1. France Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Reimbursement Scenario
      • 6.3.5.5. Competitive Scenario
    • 6.3.6. Italy
      • 6.3.6.1. Italy Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Reimbursement Scenario
      • 6.3.6.5. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Reimbursement Scenario
      • 6.3.7.5. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Reimbursement Scenario
      • 6.3.8.5. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Reimbursement Scenario
      • 6.3.9.5. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia-Pacific Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Scenario
      • 6.4.4.5. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. Competitive Scenario
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Competitive Scenario
    • 6.4.7. Australia
      • 6.4.7.1. Australia Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Competitive Scenario
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA Syphilis Testing Market, 2021 - 2033 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Syphilis Testing Market, 2021 - 2033 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. New Product Launch
    • 7.2.2. Partnerships
    • 7.2.3. Acquisition
    • 7.2.4. Collaboration
    • 7.2.5. Funding
  • 7.3. Key Company Market Share Analysis, 2024
  • 7.4. Company Heat Map Analysis
  • 7.5. Company Profiles
    • 7.5.1. Abbott Laboratories
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Bio-Rad Laboratories, Inc.
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. F. Hoffmann-La Roche Ltd
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Siemens Healthineers AG
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Danaher Corporation (Beckman Coulter)
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
    • 7.5.6. bioMerieux SA
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Thermo Fisher Scientific, Inc.
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. OraSure Technologies, Inc.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Chembio Diagnostics, Inc.
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. SD Biosensor, Inc.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 4 North America Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 5 North America Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 6 U.S. Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 7 U.S. Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 8 Canada Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 9 Canada Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 10 Europe Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 11 Europe Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 12 Europe Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 13 UK Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 14 UK Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 15 Germany Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 16 Germany Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 17 France Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 18 France Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 19 Italy Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 20 Italy Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 21 Spain Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 22 Spain Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 23 Denmark Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 24 Denmark Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 25 Sweden Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 26 Sweden Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 27 Norway Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 28 Norway Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 29 Asia Pacific Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 30 Asia Pacific Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 31 Asia Pacific Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 32 China Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 33 China Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 34 Japan Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 35 Japan Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 36 India Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 37 India Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 38 South Korea Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 39 South Korea Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 40 Australia Syphilis Testing market, by technology 2021 - 2033 (USD million)
  • Table 41 Australia Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 42 Thailand Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 43 Thailand Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 44 Latin America Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 45 Latin America Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 46 Latin America Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 47 Brazil Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 48 Brazil Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 49 Mexico Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 50 Mexico Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 51 Argentina Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 52 Argentina Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 53 Middle East & Africa Syphilis Testing market, by country, 2021 - 2033 (USD million)
  • Table 54 Middle East & Africa Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 55 Middle East & Africa Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 56 South Africa Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 57 South Africa Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 58 Saudi Arabia Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 59 Saudi Arabia Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 60 UAE Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 61 UAE Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)
  • Table 62 Kuwait Syphilis Testing market, by technology, 2021 - 2033 (USD million)
  • Table 63 Kuwait Syphilis Testing market, by Location of Testing, 2021 - 2033 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global Syphilis Testing market- Key market driver analysis
  • Fig. 7 Global Syphilis Testing market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global Syphilis Testing market - Porter's analysis
  • Fig. 10 Global Syphilis Testing market - PESTEL analysis
  • Fig. 11 Global Syphilis Testing market technology outlook key takeaways
  • Fig. 12 Global Syphilis Testing market: Technology movement analysis
  • Fig. 13 Molecular Diagnostics market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Immunoassay market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Global Syphilis Testing market Location of Testing outlook key takeaways
  • Fig. 17 Global Syphilis Testing market: Location of Testing movement analysis
  • Fig. 18 Laboratory Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Commercial/Private labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 20 Public Health Labs market estimates, 2021 - 2033 (USD Million)
  • Fig. 21 Point of Care Testing market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Global Syphilis Testing market: Regional movement analysis
  • Fig. 24 North America Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 26 Canada Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 27 Europe Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 28 UK Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 29 Germany Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 30 France Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 31 Spain Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 32 Italy Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 33 Denmark Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 34 Sweden Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 35 Norway Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 36 Asia Pacific Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 37 Japan Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 38 China Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 39 India Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 40 South Korea Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 41 Australia Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 42 Thailand Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 43 Latin America Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 44 Brazil Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 45 Mexico Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 46 Argentina Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 47 MEA Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 48 South Africa Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 49 Saudi Arabia Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 50 UAE Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 51 Kuwait Syphilis Testing market, 2021 - 2033 (USD Million)
  • Fig. 52 Strategy framework